11-Dec-14 Medtronic will turn over more than USD900 million in China this year, up from only USD50 million ten years ago. Its China strategy is multi-faceted, involving imports, local R&D, patient education and M&A. Despite this success, the advantage Medtronic - along with other foreign device makers - has carved out, is increasingly under pressure from local players, whose ability to innovate and drive costs down via frugal engineering is creating a new standard of excellence. [image: China Business Review]

10-Dec-14 Mergers and acquisitions in China’s healthcare sector rose to a record USD11.3 billion in the first 11 months of 2014, up 13% from a year earlier. A combination of ageing population and increasing affluence is driving the deal-making, coinciding with sweeping reforms by Chinese government. [image: Feucht Blog]

For more about China's healthcare sector, download our free 20-page whitepaper: China healthcare market opportunities

05-Dec-14 India produces a third of the world's medicines, mostly in the form of generic drugs. But more than 80% of the raw materials for these drugs are imported from China. That gives its neighbour a virtual monopoly over pricing and supply - so much so that there are now no domestic Indian producers of many essential medicines, a situation that worries the Indian government. [image: The Insider]

03-Dec-14 Barco has been selected by China’s Shandong Provincial Hospital group to implement a comprehensive telemedicine system across 204 hospitals and clinics in the province. [image: Barco].

28-Nov-14 Lifetech, a medical device company from Shenzhen, is in one way a pioneer in the Chinese medical device industry. Its CeraFlex occluder will enter the mainstream Western market via Medtronic’s sales channels, the first Chinese class III medical device to gain such access. However, so far, only this one product has achieved the European CE mark standard. [image: ACN Newswire]